Dr. MartensCHIX:DOCSL +0.42%52 EPS without NRI is £0.04 as of Mar. 2026. GuruFocus rates CHIX:DOCSL with a GF Score™ of 52/100 and a GF Value™ of £0.72 (Fairly Valued). The stock has 3 warning signs investors should review. Among 790 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks worse than 83.8% on this metric.
Dr. Martens's earnings per share without non-recurring items for the
six
months ended in Mar. 2026 was £0.05.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was £0.04.
During the past 12 months, Dr. Martens's average earnings per share (NRI) Growth Rate was 70.80% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -31.80% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -28.40% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Dr. Martens's EPS without NRI or its related term are showing as below:
CHIX:DOCSl'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -48.3 Med: -14.1 Max: 117.1
Current: -31.8
During the past 9 years, Dr. Martens's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 117.10% per year. The lowest was -48.30% per year. And the median was -14.10% per year.
CHIX:DOCSl's 3-Year EPS without NRI Growth Rate is ranked worse than 83.8% of 790
companies
in the Manufacturing - Apparel & Accessories industry
Industry Median: 2.15
vs CHIX:DOCSl: -31.80
Dr. Martens's EPS (Diluted) for the
six
months ended in Mar. 2026 was £0.03.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was £0.02.
Dr. Martens's EPS (Basic) for the
six
months ended in Mar. 2026 was £0.04.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was £0.03.
Dr. Martens (CHIX:DOCSl) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Dr. Martens EPS without NRI Related Terms
Dr. Martens EPS without NRI Historical Data
* Premium members only.
The historical data trend for Dr. Martens's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:DOCSL vs NKE, DECK, ONON: EPS without NRI Comparison
For the Footwear & Accessories subindustry, Dr. Martens's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens PE Ratio without NRI vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Dr. Martens's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr. Martens (CHIX:DOCSL) has a EPS without NRI of £0.04 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Dr. Martens and its competitors. According to the industry distribution chart, Dr. Martens ranks #662 out of 790 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 83.8%.
Is Dr. Martens' EPS without NRI too high?
Dr. Martens' current EPS without NRI is £0.04. Based on the distribution chart, Dr. Martens ranks #662 out of 790 companies in the Manufacturing - Apparel & Accessories industry, which is in the bottom quartile relative to peers. Overall, Dr. Martens has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' EPS without NRI compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #662 out of 790 companies for EPS without NRI. This places Dr. Martens in the lower half of its industry. The industry median EPS without NRI is 2.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Manufacturing - Apparel & Accessories company?
The median EPS without NRI among Manufacturing - Apparel & Accessories companies is 2.15, based on 790 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Dr. Martens and its competitors. For the Manufacturing - Apparel & Accessories industry, the median EPS without NRI is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current EPS without NRI is £0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (CHIX:DOCSL) is currently considered Fairly Valued. The stock's GF Value™ is £0.72, compared to a current price of £0.72 — trading 0.1% above its estimated fair value. The current EPS without NRI is £0.04. Dr. Martens' overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Dr. Martens (CHIX:DOCSL), the current EPS without NRI is £0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (CHIX:DOCSL) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be overvalued.
The current stock price of £0.72 is trading 0.1% above its estimated GF Value™ of £0.72.
GuruFocus considers Dr. Martens to be Fairly Valued.
Key valuation signals for CHIX:DOCSL:
EPS without NRI: £0.04
GF Value™: £0.72 vs. price of £0.72 (0.1% above fair value)
No single metric tells the full story. See the CHIX:DOCSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
52GF Score
Get the complete analysis for CHIX:DOCSL
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:DOCSL has been successfully added to your 
